Property and GP surgeries owner Assura (AGR.L) has agreed to be taken over by a US private equity giant in a deal worth £1.61 billion, after becoming the target of a bidding war. The London-listed company will be bought by Kohlberg Kravis Roberts (KKR) (KKR) and Stonepeak Partners. The investment groups offered 49.4p per Assura share, having increased a number of previous bids to buy the business. Assura owns more than 600 buildings, including doctors’ surgeries, with a portfolio valued at more than £3.1 billion. It has just 79 members of staff. The firm said it had rejected a different takeover approach worth £1.5 billion from real estate investment group Primary Health Properties (PHP.L) (PHP). The proposal was “not at a level that is sufficient to be recommended to shareholders”, it said. Assura chief executive Jonathan Murphy said the agreed takeover “enables the company to accelerate its growth via additional investment in critical healthcare infrastructure in the UK and Ireland”. KKR and Stonepeak plan to invest in Assura and grow the company, bringing “deep pockets and an understanding of UK infrastructure and real estate”, bosses said. KKR has shot into the spotlight recently, having been picked as a preferred bidder by troubled utility giant Thames Water. England’s biggest water firm is looking to secure a buyer to help stabilise its finances,. Last month, it said it had chosen KKR to go through a second phase of the process to secure equity investment, having received six approaches from firms. View Comments
GP surgeries owner Assura agrees to private equity takeover worth £1.61bn
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...